(This is a contributed guest column. To be considered as an MJBizDaily guest columnist, please submit your request here.)
As federal marijuana rescheduling inches closer to reality, operators must confront a fundamental shift in how legal cannabis businesses will be regulated.
Downgrading cannabis to Schedule 3 of the Controlled Substances Act signals a transition toward a federal medical model of cannabis. With that comes heightened enforcement around cybersecurity, data privacy, and compliance – requirements that many operators are not yet prepared to meet.
Medical models attract pharmaceutical investment. They also mean patients whose data is among the most highly protected in the United States.
That combination dramatically raises the stakes for cannabis businesses that collect, store, or process data — be it customer information, consumer health information, or even just employee data.
In a Schedule 3 world, cybersecurity compliance is no longer a “nice to have” or a future consideration, it is essential to survival.
What Schedule 3 means for cannabis businesses beyond 280E reform
State-regulated cannabis companies that choose to participate in a federally recognized medical framework may, for the first time, find themselves subject to a complex and overlapping web of federal and state data privacy laws.
These can include the Health Insurance Portability and Accountability Act (HIPAA), the HITECH Act, the Federal Trade Commission Act, state consumer privacy statutes, and sector-specific cybersecurity regulations that were never designed with cannabis businesses in mind.
Violations can result in criminal penalties, civil fines, regulatory investigations, notification obligations, credit monitoring expenses, and the complete loss of consumer trust.
Many cannabis operators underestimate this risk because they assume compliance obligations are tied to where their business is located. In reality, data privacy laws are very often triggered by the domicile of the data subject, not the business itself. A single out-of-state patient, consumer, or online transaction can subject a cannabis company to laws it has never evaluated, let alone complied with.
As the industry matures, participation expands, and federal scrutiny increases, ignorance of these obligations will no longer be defensible.
Marijuana rescheduling means pharmaceutical investment – and competition
At the same time, Schedule 3 opens the door to increased pharmaceutical investment and with it, a more aggressive and competitive regulatory environment. Large, well-capitalized players have strong incentives to protect their investments. This includes challenging the compliance posture of competitors.
One of the easiest ways to undermine a rival is to report potential noncompliance with cybersecurity or data privacy laws to regulators. In many cases, any member of the public can file such a complaint.
Subscribe to the MJBiz Factbook
Exclusive industry data and analysis to help you make informed business decisions and avoid costly missteps. All the facts, none of the hype.
What you will get:
- Monthly and quarterly updates, with new data & insights
- Financial forecasts + capital investment trends
- State-by-state guide to regulations, taxes & market opportunities
- Annual survey of cannabis businesses
- Consumer insights
- And more!
This represents a significant shift in risk.
In the past, cannabis compliance failures often resulted in state-level penalties or operational setbacks. In a Schedule 3 environment, cybersecurity failures can escalate quickly, causing large data breaches, drawing in federal regulators and triggering enforcement actions that extend far beyond cannabis-specific agencies.
Cannabis operators need to adapt to data regulations
The reality is that many cannabis businesses are still growing into basic data governance maturity. They are small, independently owned, and may not have a clear understanding of what data they collect, where it is stored, who has access to it, or how long it is retained.
Incident response plans are often informal or nonexistent. Vendor management, particularly point-of-sale systems, delivery platforms, and marketing tools, is frequently overlooked, despite the fact that third-party breaches can create direct liability.
In a Schedule 3 world, these gaps are no longer growing pains; they are existential threats.
How cannabis businesses can adapt information practices
To succeed, the industry must work to implement fair information practices such as collecting only what is necessary, securing it appropriately, training staff to recognize risks, and responding quickly and transparently when breaches occur.
Cybersecurity must be treated as a core compliance function, not an IT afterthought. This includes understanding which laws apply, implementing reasonable safeguards, conducting regular risk assessments, acquiring appropriate insurance, and documenting compliance efforts before something goes wrong.
Want to know if you need to worry about cybersecurity and data privacy compliance?
Use this self-assessment tool to analyze your risk.
Does my cannabis business need to worry about cybersecurity and data privacy?
- Do you collect any data, including names, addresses, phone numbers, etc., about your employees, vendors, patients, or customers?
- Do you collect drivers’ license numbers, social security numbers, state ID numbers, or passport numbers, either directly, through a POS system, or through a verification system?
- Do you collect credit card numbers, debit card numbers, financial information, or bank account information, either directly or through a payment processer?
If you answered yes to any of these three questions, your organization or business has legal obligations related to cybersecurity and data privacy.
Noncompliance with these obligations can result in criminal penalties, regulatory fines, data breaches, and loss of customer trust.
Does my cannabis business need a cybersecurity and data privacy audit?
- Do you know where your data is stored, how long it is stored, and how it is destroyed?
- Do you know who to contact and what to do in the event of a data breach?
- Do you have adequate cyber insurance to cover rebuilding your internal systems and notifying employees, customers, and regulators in the event of a breach?
- Do you know what fair information practices (FIPs) are, and do you follow them at every step of collecting, storing, using, and destroying data?
- If a vendor causes a data breach, do you know who is responsible for notifications and remediation?
If you answered no or “I don’t know” to any of these five questions, it’s time for a cybersecurity and data privacy audit.
Consider investing in a review of all vendor contracts, including seed-to-sale, point of sale, payment processing, etc., internal data life cycle policies, public-facing privacy notices, employee training, and insurance to understand your current risk profile and mitigate exposure on future events.
Cannabis cybersecurity protects the ethos of the plant
This moment represents both a challenge and an opportunity. Cannabis has long prided itself on patient advocacy, consumer trust, and community-centered values. Protecting sensitive data is a natural extension of that ethos. If the industry can mature alongside its regulatory environment, it can set a standard that balances innovation, access, and accountability.
Schedule 3 changes the incentives and the risks. Cybersecurity compliance is now a frontline issue for cannabis businesses that want to protect not only their operations, but also the people who rely on the plant.
Victoria Cvitanovic is a psychedelic medicine and cannabis attorney at Rudick Law Group, PLLC specializing in matters such as commercial transactions, regulatory compliance, state licensing, insurance, supply chain logistics, medical malpractice defense, medical board defense and corporate law.
Medical Disclaimer:
The information provided in these blog posts is intended for general informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. The use of any information provided in these blog posts is solely at your own risk. The authors and the website do not recommend or endorse any specific products, treatments, or procedures mentioned. Reliance on any information in these blog posts is solely at your own discretion.
